Stock Taper
SCREENER COMPARE ANY 2 STOCKS
MDWD
MEDIWOUND LTD.
NASDAQ
$12.66
▼ DOWN 4.38% (-0.58)

KEY STATISTICS

Market Cap$162.63 M
52w High$20.30
52w Low$12.52
Dividend Yield—
Frequency—
P/E-5.60
Volume165.53K
Shares Out.12.85M

COMPANY

LEADERSHIP

Ofer Gonen
CHIEF EXECUTIVE
Ofer Gonen

ABOUT

SECTOR
Healthcare
WENT PUBLIC
March 20, 2014
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
121

PRICE TARGET

Target High$30.00
Target Low$22.00
Target Median$26.00
Target Consensus$26.00

UPCOMING EARNINGS

DateNov 19, 2026
DayThursday
Rev. Est.$6.73M
NOV
19
THU

SPLIT RECORD

DATETYPERATIO
2022-12-20Reverse1:7

PRICE

$12.66 ▼ DOWN 4.38% (−$0.58)
OVERLAYS
$12.60$12.80$13.00$13.209:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM12.66

About MediWound Ltd.

https://www.mediwound.com ↗

MediWound Ltd. is an Israeli biopharmaceutical company developing and commercializing innovative tissue repair solutions, including NexoBrid for burn debridement and EscharEx for chronic wounds.

INDUSTRY

Biotechnology

A PRODUCT MEDIWOUND LTD. IS KNOWN FOR

NexoBrid®
NexoBrid®

NexoBrid® is a topically applied biological drug for non-surgical removal of eschar in deep burns, approved in the US, Europe, and Japan, providing a less invasive alternative to surgery.

COMPETITORS

COMPETITOR
IART COMPARE
MDXG COMPARE
ORGO COMPARE
SNN COMPARE
VCEL COMPARE

Revenue by Geography

MapREGIONFY2020
USA$18.03M

ETFS HOLDING THIS STOCK

ETFS HOLDING
36
LISTED HERE
9
RANKED BY POSITION SIZE
IWM
0.00% · 237.5K
IZRL
1.43% · 146.7K
VTWO
0.00% · 57.7K
ZPRR.DE
0.00% · 20.3K
AI
AIIQ
0.48% · 11.5K
XRS2.DE
0.00% · 9.4K
QQQS
0.45% · 7.8K
RSSL
0.00% · 4.9K
URTY
0.00% · 414

INSTITUTIONAL OWNERSHIP

SHARES OWNED
43.72%
HOLDERS
118
TOP 12 OF 118 · RANKED BY POSITION SIZE
Investor Ab
872.1K sh · $12.82M
Yelin Lapidot Holdings Management Ltd.
809.9K sh · $14.6M
Rosalind Advisors, Inc.
749.1K sh · $13.83M
Price T Rowe Associates Inc /Md/
709.8K sh · $11.44M
Blackrock, Inc.
525.9K sh · $7.73M
Blackrock Inc.
388.5K sh · $6.03M
Meitav Investment House Ltd
371.9K sh · $5.98M
KK
Kotler Kevin
337.2K sh · $6.23M
Sphera Funds Management Ltd.
273.2K sh · $4.02M
Silverberg Bernstein Capital Management LLC
228.1K sh · $3.35M
Point72 Asset Management, L.P.
175.5K sh · $2.83M
Millennium Management LLC
175.4K sh · $3.16M

RATINGS SNAPSHOT

Overall rating: C-

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity2
Price To Earnings1
Price To Book2
Overall Score1

INSIDER TRADES

★
OFFICER: COO & CHIEF COMMERCIAL OFFICER
Hess Shmuel
Sale · 5.0K shares
2026-08-26
★
OFFICER: COO & CHIEF COMMERCIAL OFFICER
Hess Shmuel
Sale · 11.0K shares
2026-08-27
★
OFFICER: COO & CHIEF COMMERCIAL OFFICER
Hess Shmuel
Sale · 2.0K shares
2026-08-27
★
OFFICER: COO & CHIEF COMMERCIAL OFFICER
Hess Shmuel
Sale · 1.9K shares
2026-08-26

MOST RECENT ANALYST GRADES

GRADE SUMMARY
OUTPERFORM 1
BUY 1
2 GRADES IN THE LAST 12 MONTHS
Oppenheimer OUTPERFORM HC Wainwright & Co. BUY

SECTORS PEERS

PEERPRICE
SLS$13.21COMPARE
OBIO$5.18COMPARE
IVVD$0.96COMPARE
RNAC$9.60COMPARE
IVA$4.71COMPARE
EPRX$6.67COMPARE
TARA$3.82COMPARE
AARD$5.79COMPARE